Tang Capital Management LLC Equillium, Inc. Transaction History

Tang Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.49 - $0.79 $152,601 - $246,031	311,432 Added 351.63%	400,000 $300,000
Q1 2023 May 15, 2023	BUY	$0.56 - $1.24 $49,598 - $109,824	88,568 New	88,568 $64,000
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.58 $2.09 Million - $3.95 Million	600,000 New	600,000 $3.21 Million
Q2 2019 Aug 14, 2019	SELL	$5.28 - $8.2 $249,971 - $388,212	-47,343 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.32 - $19.44 $299,207 - $920,347	47,343 New	47,343 $386,000

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.